Literature DB >> 20200977

Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity.

Nicola J Lee1, Kharen L Doyle, Amanda Sainsbury, Ronaldo F Enriquez, Yvonne J Hort, Sabrina J Riepler, Paul A Baldock, Herbert Herzog.   

Abstract

The neuropeptide Y (NPY) system has been implicated in the regulation of bone homeostasis and osteoblast activity, but the mechanism behind this is unclear. Here we show that Y1 receptor signaling is directly involved in the differentiation of mesenchymal progenitor cells isolated from bone tissue, as well as the activity of mature osteoblasts. Importantly, the mRNA levels of two key osteogenic transcription factors, runx2 and osterix, as well as the adipogenic transcription factor PPAR-gamma, were increased in long bones of Y1(-/-) mice compared with wild-type mice. In vitro, bone marrow stromal cells (BMSCs) isolated from Y1(-/-) mice formed a greater number of mineralized nodules under osteogenic conditions and a greater number of adipocytes under adipogenic conditions than controls. In addition, both the number and size of fibroblast colony-forming units formed in vitro by purified osteoprogenitor cells were increased in the absence of the Y1 receptors, suggestive of enhanced proliferation and osteogenesis. Furthermore, the ability of two specific populations of mesenchymal progenitor cells isolated from bone tissue, an immature mesenchymal stem cell population and a more committed osteoprogenitor cell population, to differentiate into osteoblasts and adipocytes in vitro was enhanced in the absence of Y1 receptor signaling. Finally, Y1 receptor deletion also enhanced the mineral-producing ability of mature osteoblasts, as shown by increased in vitro mineralization by BMSCs isolated from osteoblast-specific Y1(-/-) mice. Together these data demonstrate that the NPY system, via the Y1 receptor, directly inhibits the differentiation of mesenchymal progenitor cells as well as the activity of mature osteoblasts, constituting a likely mechanism for the high-bone-mass phenotype evident in Y1(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20200977     DOI: 10.1002/jbmr.61

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  41 in total

Review 1.  Body composition and skeletal health: too heavy? Too thin?

Authors:  Alexander Faje; Anne Klibanski
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

Review 2.  Osteoblastic Actions of the Neuropeptide Y System to Regulate Bone and Energy Homeostasis.

Authors:  Harry Horsnell; Paul A Baldock
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

3.  Genistein induces adipogenic differentiation in human bone marrow mesenchymal stem cells and suppresses their osteogenic potential by upregulating PPARγ.

Authors:  Li-Yan Zhang; Hao-Gang Xue; Ji-Ying Chen; Wei Chai; Ming Ni
Journal:  Exp Ther Med       Date:  2016-03-02       Impact factor: 2.447

4.  Lin28 regulates the expression of neuropeptide Y receptors and oocyte-specific homeobox genes in mouse embryonic stem cells.

Authors:  Geon Tae Park; You-Mi Seo; Su-Yeon Lee; Kyung-Ah Lee
Journal:  Clin Exp Reprod Med       Date:  2012-06-30

Review 5.  The NPY system and its neural and neuroendocrine regulation of bone.

Authors:  Ee Cheng Khor; Paul Baldock
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

6.  Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.

Authors:  Susana Galli; Arlene Naranjo; Collin Van Ryn; Jason U Tilan; Emily Trinh; Chao Yang; Jessica Tsuei; Sung-Hyeok Hong; Hongkun Wang; Ewa Izycka-Swieszewska; Yi-Chien Lee; Olga C Rodriguez; Chris Albanese; Joanna Kitlinska
Journal:  Am J Pathol       Date:  2016-10-12       Impact factor: 4.307

7.  Neuropeptide Y mediates glucocorticoid-induced osteoporosis and marrow adiposity in mice.

Authors:  F-S Wang; W-S Lian; W-T Weng; Y-C Sun; H-J Ke; Y-S Chen; J-Y Ko
Journal:  Osteoporos Int       Date:  2016-04-14       Impact factor: 4.507

Review 8.  Neural Regulation of Bone and Bone Marrow.

Authors:  Maria Maryanovich; Shoichiro Takeishi; Paul S Frenette
Journal:  Cold Spring Harb Perspect Med       Date:  2018-09-04       Impact factor: 6.915

9.  Skeletal phenotype of the neuropeptide Y knockout mouse.

Authors:  Natalie K Y Wee; Benjamin P Sinder; Sanja Novak; Xi Wang; Chris Stoddard; Brya G Matthews; Ivo Kalajzic
Journal:  Neuropeptides       Date:  2018-11-30       Impact factor: 3.286

Review 10.  Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology.

Authors:  Jason Tilan; Joanna Kitlinska
Journal:  Neuropeptides       Date:  2015-10-26       Impact factor: 3.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.